General Information of the Compound
| Compound ID |
CP0437050
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(4S)-4-benzyl-3-[2-(2-bicyclo[2.2.1]heptanyl)ethyl]-1-[4-[(5S)-2-propyl-4,5-dihydro-1H-imidazol-5-yl]butyl]imidazolidine-2-thione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H44N4S
|
||||||||||||||||||
| Molecular Weight |
480.766
|
||||||||||||||||||
| Canonical SMILES |
CCCC1=N[C@@H](CCCCN2C[C@H](Cc3ccccc3)N(CCC3CC4CCC3C4)C2=S)CN1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H44N4S/c1-2-8-28-30-20-26(31-28)11-6-7-15-32-21-27(19-22-9-4-3-5-10-22)33(29(32)34)16-14-25-18-23-12-13-24(25)17-23/h3-5,9-10,23-27H,2,6-8,11-21H2,1H3,(H,30,31)/t23?,24?,25?,26-,27-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BHSQXIQZFCCWQV-CTEMSKPWSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02658, Nuclear receptor ROR-alpha
Protein ID: PT06515, Nuclear receptor ROR-beta
Protein ID: PT05439, Nuclear receptor ROR-gamma